Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.07
BICX's Cash to Debt is ranked lower than
75% of the 348 Companies
in the Global Medical Care industry.

( Industry Median: 0.19 vs. BICX: 0.07 )
BICX' s 10-Year Cash to Debt Range
Min: 0.02   Max: No Debt
Current: 0.07

Equity to Asset 0.08
BICX's Equity to Asset is ranked lower than
77% of the 339 Companies
in the Global Medical Care industry.

( Industry Median: 0.42 vs. BICX: 0.08 )
BICX' s 10-Year Equity to Asset Range
Min: -14.42   Max: 0.77
Current: 0.08

-14.42
0.77
F-Score: 6
Z-Score: -3.38
M-Score: -6.83
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -260.72
BICX's Operating margin (%) is ranked lower than
75% of the 349 Companies
in the Global Medical Care industry.

( Industry Median: 9.26 vs. BICX: -260.72 )
BICX' s 10-Year Operating margin (%) Range
Min: -349.65   Max: -44.56
Current: -260.72

-349.65
-44.56
Net-margin (%) -267.04
BICX's Net-margin (%) is ranked lower than
75% of the 349 Companies
in the Global Medical Care industry.

( Industry Median: 4.59 vs. BICX: -267.04 )
BICX' s 10-Year Net-margin (%) Range
Min: -536.92   Max: -52.98
Current: -267.04

-536.92
-52.98
ROE (%) -2199.02
BICX's ROE (%) is ranked lower than
79% of the 330 Companies
in the Global Medical Care industry.

( Industry Median: 11.00 vs. BICX: -2199.02 )
BICX' s 10-Year ROE (%) Range
Min: -1182.61   Max: -24.66
Current: -2199.02

-1182.61
-24.66
ROA (%) -70.69
BICX's ROA (%) is ranked lower than
74% of the 355 Companies
in the Global Medical Care industry.

( Industry Median: 4.18 vs. BICX: -70.69 )
BICX' s 10-Year ROA (%) Range
Min: -1550   Max: -18.07
Current: -70.69

-1550
-18.07
ROC (Joel Greenblatt) (%) -40171.05
BICX's ROC (Joel Greenblatt) (%) is ranked lower than
74% of the 352 Companies
in the Global Medical Care industry.

( Industry Median: 17.58 vs. BICX: -40171.05 )
BICX' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -40706.67   Max: -6254.55
Current: -40171.05

-40706.67
-6254.55
Revenue Growth (3Y)(%) -20.60
BICX's Revenue Growth (3Y)(%) is ranked lower than
101% of the 258 Companies
in the Global Medical Care industry.

( Industry Median: 8.50 vs. BICX: -20.60 )
BICX' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0   Max: -20.6
Current: -20.6

EBITDA Growth (3Y)(%) 26.00
BICX's EBITDA Growth (3Y)(%) is ranked lower than
124% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 7.30 vs. BICX: 26.00 )
BICX' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 26
Current: 26

0
26
EPS Growth (3Y)(%) 26.00
BICX's EPS Growth (3Y)(%) is ranked lower than
132% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 9.00 vs. BICX: 26.00 )
BICX' s 10-Year EPS Growth (3Y)(%) Range
Min: 0   Max: 26
Current: 26

0
26
» BICX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with BICX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/S 11.27
BICX's P/S is ranked lower than
65% of the 400 Companies
in the Global Medical Care industry.

( Industry Median: 1.92 vs. BICX: 11.27 )
BICX' s 10-Year P/S Range
Min: 0.9   Max: 21.5
Current: 11.27

0.9
21.5
Current Ratio 0.11
BICX's Current Ratio is ranked lower than
76% of the 342 Companies
in the Global Medical Care industry.

( Industry Median: 1.34 vs. BICX: 0.11 )
BICX' s 10-Year Current Ratio Range
Min: 0.07   Max: 1
Current: 0.11

0.07
1
Quick Ratio 0.11
BICX's Quick Ratio is ranked lower than
76% of the 342 Companies
in the Global Medical Care industry.

( Industry Median: 1.12 vs. BICX: 0.11 )
BICX' s 10-Year Quick Ratio Range
Min: 0.07   Max: 1
Current: 0.11

0.07
1
Days Sales Outstanding 24.62
BICX's Days Sales Outstanding is ranked lower than
65% of the 400 Companies
in the Global Medical Care industry.

( Industry Median: 52.95 vs. BICX: 24.62 )
BICX' s 10-Year Days Sales Outstanding Range
Min: 24.62   Max: 452.04
Current: 24.62

24.62
452.04

Valuation & Return

vs
industry
vs
history
Earnings Yield (Greenblatt) -22.60
BICX's Earnings Yield (Greenblatt) is ranked lower than
76% of the 345 Companies
in the Global Medical Care industry.

( Industry Median: 4.20 vs. BICX: -22.60 )
BICX' s 10-Year Earnings Yield (Greenblatt) Range
Min: -20.6   Max: 0
Current: -22.6

-20.6
0

Business Description

Industry: Health Care Providers » Medical Care
Compare: » details
Fresh Start Private Management, Inc., a Nevada corporation on January 28, 2008 as Cetrone Energy Company. On July 26, 2010, the Company changed its name to Fresh Start Private Management Inc. Through its wholly owned subsidiary, it is an alcohol rehabilitation and treatment center. The company was established in January 2010 and is currently operating in Santa Ana, California. Its alcohol rehabilitation program consists of a Naltrexone implant that is placed under the skin in the lower abdomen coupled with life counseling sessions from specialized counselors. The Company operates within the Specialty Hospitals, Expert Psychiatric industry, specifically within the industry subsets of Alcoholism Rehabilitation Hospital. It has created an innovative alcohol treatment program that empowers patients to succeed in their overall recovery. The Company offers a treatment philosophy that combines medical intervention, a singular focus and a comprehensive approach, and a focus on family and friends. It has been operating for approximately 36 months and has treated over 150 patients. Currently, it is treating about 2 to 3 patients per week. The alcohol treatment services costs an average of $49,300 per patient and is typically covered by insurance. The Company faces competition with the other rehabilitation service providers.
» More Articles for BICX

Headlines

Articles On GuruFocus.com
Health Care Sector in an Upward Climb in June Jun 12 2014 
Two Promising Health Care Stocks with Market Capitalizations Under $500 Million Jun 11 2014 

More From Other Websites
10-K for BioCorRx, Inc. Apr 26 2015
BioCorRx, Inc. Announces Start Date of Start Fresh Program(r) Pilot at Wellness Center in Corona, CA Apr 14 2015
BIOCORRX INC. Financials Apr 07 2015
BioCorRx, Inc. Reports 2014 Financial Results Apr 02 2015
BIOCORRX INC. Files SEC form 10-K, Annual Report Mar 31 2015
Small Cap IR Correction -- BioCorRx Inc. Positions Itself Through Strategic Partnerships To Gain... Mar 27 2015
/DISREGARD RELEASE: Small Cap IR/ Mar 27 2015
Brady Granier, Chief Operating Officer and Interim Chief Executive Officer of BioCorRx, Inc.,... Mar 26 2015
BioCorRx, Inc. Enters Definitive Agreement with Myriad Medical Marketing to Introduce Start Fresh... Mar 25 2015
BIOCORRX INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements... Mar 24 2015
Wealthmakers.com Initiates Coverage on BioCorRx (BICX) Mar 23 2015
BioCorRx, Inc. Announces Reinstatement of Letter of Understanding to Acquire Naltrexone Implant... Mar 18 2015
BIOCORRX INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements... Mar 18 2015
BIOCORRX INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements... Mar 13 2015
BioCorRx, Inc. Enters into Supply Agreement to Distribute Start Fresh Program(r) through Established... Mar 12 2015
BioCorRx, Inc. and MyLife Recovery CentersTM Announce Availability of the Start Fresh Program(r) for... Mar 09 2015
BioCorRx Retains BUYINS.NET To Surveil Short Sellers and Market Makers Mar 06 2015
BioCorRx, Inc. Enters into LOI with Myriad Medical Marketing to Introduce Start Fresh Program in... Feb 27 2015
BIOCORRX INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements... Feb 26 2015
BIOCORRX INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of... Feb 06 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK